AstraZeneca’s vaccine for COVID-19
-
Phase 2 trials often are ‘multiple ascending dose’ since they’re trying to balance safety and efficacy, which are presumed to be a trade off, and neither of which are known with much confidence going in.
What gets me is the lighter dose being more effective. Want to know their n and that it wasn’t just noise.
-
Could anyone explain "This is the only western vaccine in such late stage without a stabilized Spike in the pre-fusion conformation." to me?
@Klaus said in AstraZeneca’s vaccine for COVID-19:
Could anyone explain "This is the only western vaccine in such late stage without a stabilized Spike in the pre-fusion conformation." to me?
https://www.pnas.org/content/114/35/E7348
U figure it out
-
Phase 2 trials often are ‘multiple ascending dose’ since they’re trying to balance safety and efficacy, which are presumed to be a trade off, and neither of which are known with much confidence going in.
What gets me is the lighter dose being more effective. Want to know their n and that it wasn’t just noise.
-
Phase 2 trials often are ‘multiple ascending dose’ since they’re trying to balance safety and efficacy, which are presumed to be a trade off, and neither of which are known with much confidence going in.
What gets me is the lighter dose being more effective. Want to know their n and that it wasn’t just noise.
@jon-nyc said in AstraZeneca’s vaccine for COVID-19:
Phase 2 trials often are ‘multiple ascending dose’ since they’re trying to balance safety and efficacy, which are presumed to be a trade off, and neither of which are known with much confidence going in.
What gets me is the lighter dose being more effective. Want to know their n and that it wasn’t just noise.
Wait, this wasn’t a ‘multiple ascending dose’ P2. It was p3 and the light dosing was an accident. Fairly low n of 3k. They’re going to have some explaining to do.